Literature DB >> 23422318

Lymph node invasion might have more prognostic impact than R status in advanced esophageal adenocarcinoma.

Magali Cabau1, Guillaume Luc, Eric Terrebonne, Geneviève Belleanne, Véronique Vendrely, Antonio Sa Cunha, Denis Collet.   

Abstract

BACKGROUND: Advanced esophageal adenocarcinomas are associated with 5-year survival rates ranging from 14% to 35%. Nodal status and tumor clearance are the main prognostic factors. However, their respective prognostic values have not been compared to date.
METHODS: Seventy consecutive patients with stage T3 adenocarcinomas of the esophagus or gastric cardia were retrospectively assessed. Neoadjuvant therapy was indicated in all cases. Prognostic values of R0 resection and nodal status were evaluated using univariate and multivariate analyses.
RESULTS: Neoadjuvant therapy was achieved in 62 patients, 41 with radiochemotherapy and 21 with perioperative chemotherapy. Transthoracic esophagectomy and transhiatal esophagectomy were performed in 54 and 15 patients, respectively. Clavien-Dindo grade III or IV complications occurred in 16 patients (23%). Two patients died in the hospital (3%). In univariate and multivariate analyses, nodal status was the main independent factor predicting overall survival; tumor clearance (R0 or R1) had less prognostic impact and was not statistically significant. Furthermore, R1 resection was a prognostic indicator for metastatic recurrence.
CONCLUSIONS: These results indicate that nodal status has more prognostic impact than R status in stage T3 adenocarcinomas of the esophagus or gastric cardia. Thus, local control in R1 patients by postoperative radiotherapy is not justified.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23422318     DOI: 10.1016/j.amjsurg.2012.08.009

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma.

Authors:  Arianna Barbetta; Francisco Schlottmann; Tamar Nobel; David B Sewell; Meier Hsu; Kay See Tan; Hans Gerdes; Pari Shah; Manjit S Bains; Matthew Bott; James M Isbell; David R Jones; Daniela Molena
Journal:  Ann Thorac Surg       Date:  2018-04-05       Impact factor: 4.330

Review 2.  [R1 resection of esophageal carcinoma].

Authors:  I Gockel; C Wittekind
Journal:  Chirurg       Date:  2017-09       Impact factor: 0.955

Review 3.  Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.

Authors:  Wade T Iams; Victoria M Villaflor
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

Review 4.  Endoscopic Treatment of High-Grade Dysplasia and Early Esophageal Cancer.

Authors:  Francisco Schlottmann; Marco G Patti; Nicholas J Shaheen
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

5.  Identification of the Lymphatic Drainage Pattern of Esophageal Cancer with Near-Infrared Fluorescent Imaging.

Authors:  Francisco Schlottmann; Arianna Barbetta; Benedetto Mungo; Anne O Lidor; Daniela Molena
Journal:  J Laparoendosc Adv Surg Tech A       Date:  2016-12-19       Impact factor: 1.878

Review 6.  Current Concepts in Treatment of Barrett's Esophagus With and Without Dysplasia.

Authors:  Francisco Schlottmann; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2017-03-28       Impact factor: 3.452

7.  Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases.

Authors:  Daniela Molena; Francisco Schlottmann; Joshua A Boys; Shanda H Blackmon; Karen J Dickinson; Christy M Dunst; Wayne L Hofstetter; Michal J Lada; Brian E Louie; Benedetto Mungo; Thomas J Watson; Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2016-08-25       Impact factor: 3.452

8.  Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer.

Authors:  Andreas Fountoulakis; John Souglakos; Louiza Vini; Gerasimos N Douridas; Anna Koumarianou; Panteleimon Kountourakis; Christos Agalianos; Andreas Alexandrou; Christos Dervenis; Sofia Gourtsoyianni; Nikolaos Gouvas; Maria-Angeliki Kalogeridi; Georgia Levidou; Theodoros Liakakos; Joseph Sgouros; Spiros N Sgouros; Charikleia Triantopoulou; Evangelos Xynos
Journal:  Updates Surg       Date:  2019-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.